Nasdaq: JUNO

Juno Therapeutics, Inc.

Juno is part of Foresite’s immune therapy leadership investment effort. Juno is a clinical-stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies.